0
contact-banner

Ponesimod

Ponesimod

API0233561

Ponesimod

Ponatinib Hydrochloride is an anticancer drug and a tyrosine kinase inhibitor.

Inquiry
API Description
API Details
Document
Related Patent Status
  • CAS No.

    854107-55-4

  • Synonyms

    Ponesimod; 854107-55-4; ACT-128800

  • CHEMBL ID

  • Indications

  • Molecule Type

    Small molecule

  • Compound CID

    11363176

  • Molecular Weight (g/mol)

    461

  • Molecular Formula

    C23H25ClN2O4S

  • InChI

    InChI=1S/C23H25ClN2O4S/c1-3-10-25-23-26(19-7-5-4-6-15(19)2)22(29)21(31-23)12-16-8-9-20(18(24)11-16)30-14-17(28)13-27/h4-9,11-12,17,27-28H,3,10,13-14H2,1-2H3/b21-12-,25-23?/t17-/m1/s1

  • InChIKey

    LPAUOXUZGSBGDU-ULCCENQXSA-N

  • SMILES

    CCCN=C1N(C(=O)/C(=C/C2=CC(=C(C=C2)OC[C@@H](CO)O)Cl)/S1)C3=CC=CC=C3C

  • IUPAC Name

    (5Z)-5-[[3-chloro-4-[(2R)-2,3-dihydroxypropoxy]phenyl]methylidene]-3-(2-methylphenyl)-2-propylimino-1,3-thiazolidin-4-one

  • Exact Mass (Da)

    460.1223562

  • Monoisotopic Mass (Da)

    460.1223562

OUR PRODUCTS